-
-
In this issue: Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions.
-
Following a chart review that indicated few (24%) medical ICU (MICU) patients received consultation for physical therapy (PT) or occupational therapy (OT) a percentage almost 50% lower than at two other academic medical centers in the same city as well as a higher prevalence of deep sedation, the authors elected to initiate a QI project designed to reduce the use of deep sedation and improve patients' functional ability.
-
-
Desai and colleagues carried out a comprehensive review of published studies on long-term complications among survivors of critical illness in an attempt to find common characteristics and themes that might be used in developing strategies for preventing or mitigating them.
-
Acetaminophen (known as paracetamol outside the United States) is the most commonly used analgesic in the world, usually considered to be safe and benign.
-
-
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
Several recent studies examine the contributions of imaging, biomarkers, and neuropsychological testing to a refined understanding of the syndromes collectively known as primary progressive aphasia.
-
Children with H1N1 influenza are more likely to have neurologic complications compared to those with non-N1H1 seasonal influenza